Seroconversion to islet autoantibodies after enterovirus infection in early pregnancy

Viral Immunology

Volumn 25, Issue 4, 2012, Pages 254-261

  Rešić Lindehammer, Sabina ^a   Honkanen, Hanna ^b   Nix, William Allan ^c   Oikarinen, Maarit ^b   Lynch, Kristian Francis ^a   Jönsson, Ida ^a   Marsal, Karel ^d   Oberste, Steven ^c   Hyöty, Heikki ^b,e   Lernmark, Åke ^a  

^a LUND UNIVERSITY   (Sweden)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; IMMUNOGLOBULIN M; INSULIN ANTIBODY; ISLET ANTIGEN 2 AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

AGE; ARTICLE; CONTROLLED STUDY; ENTEROVIRUS; ENTEROVIRUS INFECTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GENOTYPE; HLA SYSTEM; HUMAN; PANCREAS ISLET CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROTYPE;

ADULT; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; IMMUNOGLOBULIN M; ISLETS OF LANGERHANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84865010272     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2012.0022     Document Type: Article

References (39)

1. Atkinson MA, and Eisenbarth GS: Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-229.
2. Bruserud O, Jervell J, and Thorsby E: HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and coxsackie B4 virus: Studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 1985;28:420-426.
3. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, and Diderholm H: Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995;38:1371-1373.
4. Dahlquist GG, Boman JE, and Juto P: Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhoodonset IDDM in offspring. Diabetes Care 1999;22:364-365.
5. Eisenbarth GS: Prediction of type 1 diabetes: The natural history of the prediabetic period. Adv Exp Med Biol 2004; 552:268-290.
6. Eising S, Nilsson A, Carstensen B, et al.: Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes. Eur J Endocrinol 2010;164:247-252.
7. Elfving M, Svensson J, Oikarinen S, et al.: Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age. Exp Diabetes Res 2008;2008:271958.
8. Erlich H: Polymorphism at HLA-DPA1 and DPB1 is associated with type 1 diabetes risk (T1D). Tissue Antigens 2008;72:239-239.
9. Forrest JM, Menser MA, and Burgess JA: High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971;2:332-334.
10. Germer JJ, Lins MM, Jensen ME, et al.: Evaluation of the MagNA pure LC instrument for extraction of hepatitis C virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, version 2.0. J Clin Microbiol 2003;41:3503-3508.
11. Graves PM, Rotbart HA, Nix WA, et al.: Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract 2003;59:51-61.
12. Grubin CE, Daniels T, Toivola B, et al.: A novel radioligand binding assay to determine diagnostic accuracy of isoformspecific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-350.
13. Hiltunen M, Hyoty H, Knip M, et al.: Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J Infect Dis 1997;175:554-560.
14. Hyoty H, Hiltunen M, Knip M, et al.: A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995;44:652-657.
15. Ilonen J, Reijonen H, Herva E, et al.: Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1996;19: 795-800.
16. Karvonen M: Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabetic Med 2006;23:857-866.
17. Kilpatrick DR, Yang CF, Ching K, et al.: Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol, 2009;47:1939-1941.
18. La Torre D, and Lernmark A: Immunology of beta-cell destruction. Adv Exp Med Biol 2010;654:537-583.
19. Larsson HE, Hansson G, Carlsson A, et al.: Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes. Diabetologia 2008;51:1623-1630.
20. Larsson K, Elding-Larsson H, Cederwall E, et al.: Genetic and perinatal factors as risk for childhood type 1 diabetes. Diabetes Metab Res Rev 2004;20:429-437.
21. Lindberg B, Ivarsson SA, Landin-Olsson M, Sundkvist G, Svanberg L, and Lernmark A: Islet autoantibodies in cord blood fromchildrenwho developed type I (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia 1999;42: 181-187.
22. Lindehammer SR, Hansson I, Midberg B, Ivarsson SA, Lynch KF, Dillner J, and Lernmark A: Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers. J Reprod Immunol 2010;88:72-79.
23. Lonnrot M, Salminen K, Knip M, et al.: Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: A prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 2000;61:214-220.
24. Lynch KF, Lernmark B, Merlo J, Cilio CM, Ivarsson SA, and Lernmark A: Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J Perinatol 2008;28:211-217.
25. Nix WA, Oberste MS, and Pallansch MA: Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006;44:2698-2704.
26. Oberste MS, Penaranda S, Rogers SL, Henderson E, and Nix WA: Comparative evaluation of Taqman real-time PCR and semi-nested VP1 PCR for detection of enteroviruses in clinical specimens. J Clin Virol 2010;49:73-74.
27. Patterson CC, Dahlquist GG, Gyurus E, Green A, and Soltesz G: Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet 2009; 373:2027-2033.
28. Rolandsson O, Hagg E, Janer M, et al.: High GAD65 autoantibody levels in nondiabetic adults are associated with HLA but not with CTLA-4 or INS VNTR. J Intern Med 2003; 253:447-453.
29. Ryding J, French KM, Naucler P, Barnabas RV, Garnett GP, and Dillner J: Seroepidemiology as basis for design of a human papillomavirus vaccination program. Vaccine 2008; 26:5263-5268.
30. Sadeharju K, Knip M, Hiltunen M, Akerblom HK, and Hyoty H: The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 2003;46:1100-1105.
31. Salminen K, Sadeharju K, Lonnrot M, et al.: Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003;69;91-98.
32. Schernthaner G, Banatvala JE, Scherbaum W, Bryant J, Borkenstein M, Schober E, and Mayr WR: Coxsackie-Bvirus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 1985;2:630-632.
33. Stene LC, Oikarinen S, Hyoty H, et al.: Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: The Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010;59:3174-3180.
34. Sterner Y, Torn C, Lee HS, et al.: Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics. J Perinatol 2011;12:764-769.
35. Torn C, Mueller PW, Schlosser M, Bonifacio E, and Bingley PJ: Diabetes antibody standardization program: Evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008;51:846-852.
36. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, and Gale EAM: A novel micro-Assay for insulin autoantibodies. J Autoimmunity 1997;10:473-478.
37. Viskari H, Knip M, Tauriainen S, et al.: Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring. Diabetes Care 2012 [Epub ahead of print].
38. Viskari HR, Roivainen M, Reunanen A, et al.: Maternal firsttrimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes 2002;51;2568-2571.
39. Yin H, Berg AK, Tuvemo T, and Frisk G: Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002;51:1964-1971.